Esperion Therapeutics Stock Price Patterns
| ESPR Stock | USD 3.39 0.16 4.51% |
Momentum 32
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter 0.2733 | EPS Estimate Current Year (0.05) | EPS Estimate Next Year 0.0614 | Wall Street Target Price 6.5013 | EPS Estimate Current Quarter (0.07) |
Using Esperion Therapeutics hype-based prediction, you can estimate the value of Esperion Therapeutics from the perspective of Esperion Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Esperion Therapeutics using Esperion Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Esperion using crowd psychology based on the activity and movement of Esperion Therapeutics' stock price.
Esperion Therapeutics Short Interest
An investor who is long Esperion Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Esperion Therapeutics and may potentially protect profits, hedge Esperion Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 2.2356 | Short Percent 0.1585 | Short Ratio 6.69 | Shares Short Prior Month 33.9 M | 50 Day MA 3.5712 |
Esperion Therapeutics Hype to Price Pattern
Investor biases related to Esperion Therapeutics' public news can be used to forecast risks associated with an investment in Esperion. The trend in average sentiment can be used to explain how an investor holding Esperion can time the market purely based on public headlines and social activities around Esperion Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Esperion Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Esperion Therapeutics.
Esperion Therapeutics Implied Volatility | 1.22 |
Esperion Therapeutics' implied volatility exposes the market's sentiment of Esperion Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Esperion Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Esperion Therapeutics stock will not fluctuate a lot when Esperion Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Esperion Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Esperion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Esperion Therapeutics after-hype prediction price | USD 3.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Esperion contract
Based on the Rule 16, the options market is currently suggesting that Esperion Therapeutics will have an average daily up or down price movement of about 0.0763% per day over the life of the 2026-03-20 option contract. With Esperion Therapeutics trading at USD 3.39, that is roughly USD 0.002585 . If you think that the market is fully incorporating Esperion Therapeutics' daily price movement you should consider acquiring Esperion Therapeutics options at the current volatility level of 1.22%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Esperion Therapeutics Basic Forecasting Models to cross-verify your projections. Esperion Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Esperion Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Esperion Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Esperion Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Esperion Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Esperion Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Esperion Therapeutics' historical news coverage. Esperion Therapeutics' after-hype downside and upside margins for the prediction period are 0.17 and 8.26, respectively. We have considered Esperion Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Esperion Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Esperion Therapeutics is based on 3 months time horizon.
Esperion Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Esperion Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Esperion Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Esperion Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.34 | 4.83 | 0.05 | 0.06 | 10 Events / Month | 8 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.39 | 3.39 | 0.00 |
|
Esperion Therapeutics Hype Timeline
Esperion Therapeutics is currently traded for 3.39. The entity has historical hype elasticity of 0.05, and average elasticity to hype of competition of -0.06. Esperion is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.34%. %. The volatility of related hype on Esperion Therapeutics is about 2653.85%, with the expected price after the next announcement by competition of 3.33. About 48.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.54. Esperion Therapeutics had not issued any dividends in recent years. The entity had 1:6 split on the 11th of June 2013. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out Esperion Therapeutics Basic Forecasting Models to cross-verify your projections.Esperion Therapeutics Related Hype Analysis
Having access to credible news sources related to Esperion Therapeutics' direct competition is more important than ever and may enhance your ability to predict Esperion Therapeutics' future price movements. Getting to know how Esperion Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Esperion Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SNDL | SNDL Inc | (0.04) | 9 per month | 0.00 | (0.1) | 5.06 | (5.88) | 37.98 | |
| SIGA | SIGA Technologies | (0.17) | 9 per month | 0.00 | (0.11) | 3.56 | (3.08) | 23.51 | |
| AQST | Aquestive Therapeutics | (0.39) | 10 per month | 0.00 | (0.19) | 5.36 | (7.62) | 45.05 | |
| EBS | Emergent Biosolutions | 0.22 | 20 per month | 4.20 | 0.06 | 8.06 | (4.71) | 52.54 | |
| VTYX | Ventyx Biosciences | (1.59) | 8 per month | 3.30 | 0.21 | 14.25 | (6.33) | 37.04 | |
| CRVS | Corvus Pharmaceuticals | (0.46) | 7 per month | 2.89 | 0.13 | 9.63 | (6.97) | 174.29 | |
| OLMA | Olema Pharmaceuticals | (0.18) | 8 per month | 2.95 | 0.15 | 9.82 | (5.86) | 145.73 | |
| OFIX | Orthofix Medical | 0.06 | 6 per month | 0.00 | (0.14) | 3.30 | (3.62) | 11.43 | |
| ABSI | Absci Corp | (0.07) | 9 per month | 0.00 | (0.07) | 8.58 | (7.91) | 27.80 | |
| RGNX | Regenxbio | 0.80 | 8 per month | 0.00 | (0.02) | 7.94 | (6.66) | 27.87 |
Esperion Therapeutics Additional Predictive Modules
Most predictive techniques to examine Esperion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Esperion using various technical indicators. When you analyze Esperion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Esperion Therapeutics Predictive Indicators
The successful prediction of Esperion Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Esperion Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Esperion Therapeutics based on analysis of Esperion Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Esperion Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Esperion Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 1.36 | 1.33 | 1.2 | 1.26 | Days Of Inventory On Hand | 553.6 | 502.75 | 578.16 | 1.1K |
Pair Trading with Esperion Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Esperion Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Esperion Stock
| 0.77 | ACLX | Arcellx | PairCorr |
| 0.59 | RANI | Rani Therapeutics | PairCorr |
| 0.59 | APLT | Applied Therapeutics | PairCorr |
| 0.56 | EVGN | Evogene | PairCorr |
| 0.51 | RNAZ | Transcode Therapeutics | PairCorr |
| 0.5 | ALKS | Alkermes Plc | PairCorr |
The ability to find closely correlated positions to Esperion Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Esperion Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Esperion Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Esperion Therapeutics to buy it.
The correlation of Esperion Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Esperion Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Esperion Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Esperion Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.